Join us for a sophisticated jaunt around San Diego’s largest natural harbor on the 58 foot SUNCHASER American Catamaran, The Aolani. Network with other participants while enjoying  the 360 degree views of the stunning San Diego skyline, tasting and learning about a variety of wines, and enjoy a savory lunch. 

Attire: We suggest that you be sure to bring a jacket as the weather on the bay can get windy  and will be cooler on board than San Diego's seasonal temperatures in March (mid 60s).

Sponsor Registration & Orientation Reception

Runs Concurrently With:

Participant Meet 'n Greet

This "participant only" vendor-free networking activity will offer you the unique opportunity to identify early on, peers facing similar challenges and help to facilitate a future dialogue later in the program

Island Luau Welcome Networking Reception & Event Kickoff

Kick off our 18th annual event in-style! Join us for rum punches, island breezes and casual conversation. Connect with your fellow peers and colleagues while you get ready for the days ahead!

Greg Caressi, Senior Vice President, Healthcare & Life Sciences, Frost & Sullivan

To start off this year's event, Frost & Sullivan will put forward our view of megashifts that we expect to see in the healthcare world of 2025. This view of the future will provide three big predictions.  We'll share our view of the future and invite others to add their big predictions, as a way for us as a group to discuss key industry trends and the possible outcomes and impacts on the healthcare system and the market for medical technologies.

Key Take-Aways:

• Roadmap for the coming alternative to primary care as we have
  known it
• Insight on segmentation, stratification and individualization that will change private payer plans
• Framework for the impact of the widening world of stakeholders in the future healthcare system

Mapping Success in an Outcomes-Driven Healthcare Environment

Jim Hollingshead, President, Americas, ResMed

Outcomes-driven care carries wide-ranging implications for the Medical Device market. There are hidden opportunities in this environment that will create a divide between category winners and losers.

Key Take-Aways:

• Insights into how outcomes-driven medicine influences go-to-market strategy for medical devices
• Leveraging medical research to inform and reset payer agendas
• Creating compliance systems to align with personalized medicine

Breakout Sessions: Create, Communicate & Connect

Participant-driven discussions focusing on your key challenges
and concerns.

Choose one of the following:

RT1. Untangling the Intangible: Translating Innovative Ideas into Successful Products

FACILITATOR:
Gillian Davies, PhD, Senior Consultant, Health Technology, Sagentia

As healthcare provision increasingly focuses on outcomes and cost reduction the drive for disruptive innovation ways heavier.  Adapting to these market shifts will be critical to the continued success of businesses operating in the medical space, but getting it right may require a different approach to R&D if companies are to provide the new paradigm of solution-based products in the emerging connected healthcare system.

Key Take-Aways:

• A framework to ensure that your teams are evaluating the right opportunities in the right way
• Tools and techniques to help you systematically deliver on your organization's innovation mandates
• The 5 most common pitfalls: how to identify them and how to avoid them

RT2. Addressing the Whole Challenge: Understanding Customers’ Issues, Identifying Gaps, and Partnering to Create Complete Solutions

CO-FACILITATOR:
 
Sheila Mello, Principal, Product Development Consulting, Inc. (PDC)

Monica Rassai, Global Product Director, Advanced Sterilization Products, a Johnson & Johnson Company

Too many companies have ceded market share—or even been swallowed up by entirely new industries—as a result of thinking too narrowly about their businesses. This interactive session will explore concrete ways to deliver a breadth of solutions by meeting the customer's requirements, working with your core capabilities, and aligning with other vendors to fully solve the customer's problem.

Key Take-Aways:

• Action steps to fully understand the problems that plague your target customers - regardless of any specific product that might solve them
• Best practices for working effectively with partners to address gaps in your core capabilities
• Insight on addressing emerging market challenges and opportunities

RT3. Strategic Planning for Safe, Interoperable Healthcare

CO-FACILITATORS:
Terenzio Facchinetti, PharmD, Business Development Manager - Life and Health Sciences, UL

Shahid Shah, President & Chief Executive Officer, Netspective Communications

Though a favored buzz word - “interoperability” - does everybody have the same definition and understanding of its importance? How does interoperability affect the healthcare value chain whether it is the hospital(intensive care), remote(home healthcare), or electronic health patient records? How can we also address the concerns that revolve around safety and security in EHR/EMR data exchange?
 
Key Take-Aways:

• Guide to the current work and future trends of “Interoperable Healthcare”
• Value of proprietary and open approaches
• Insights on regulatory challenges and examples of thought leaders who will trigger changes

CONCURRENT SESSIONS

Solutions Wheel

Play the “wheel” and join a series of rapid-fire, one-on-one meetings with
leading solution providers.

Runs concurrently with:

COLLABORATION CHALLENGE – In a Brave New Regulatory World, Who is Your Brave New Regulatory Leader?

Tamima Itani, Vice President, Global Regulatory Affairs, Boston Scientific

As new countries adopt regulations for medical devices, and countries with existing regulatory frameworks continue to expand them, the profile of the desirable regulatory executive is evolving.  A gap in regulatory talent at the highest levels is emerging, with implications across the product development process and go-to-market strategies.

Key Take-Aways:

• Key challenges and opportunities in the evolving worldwide regulatory environment
• Insight on the dearth of the executive regulatory pipeline - skills and capability gaps
• Rallying to ensure the future regulatory competitiveness of our industry

The Power Lunch - Networking Roundtables Hosted by Industry
Leaders

Practitioners and solution providers host a menu of luncheon discussions
on pertinent industry issues. Dine and dish with industry experts. The list
of discussion topics will be available onsite.

Session to Session Travel Time

Breakout Sessions: Create, Communicate & Connect

Participant-driven discussions focusing on your key challenges
and concerns.

Choose one of the following:

BP1. Design for Excellence: Developing Products for Global Success

CO-FACILITATORS:
Josh Hinnendael, Director of Project Management, Engineering Solutions, Plexus

Samir Shah, Senior Director, Program Management and Remote Care Operations, St. Jude Medical

Cost pressures have become a global reality within healthcare and life sciences, forcing all device manufacturers to offer lower cost products in all global regions to be successful. This interactive session will discuss methods and procedures for finding the lowest total cost of ownership.

Key Take-Aways:

• Best practices during concept and design to: efficiently get to workable requirements, achieving reliability goals, and designing in the proper supply chain
• Avoiding the pitfalls during transition from 'design' to volume manufacturing; meeting the time to market goals that are critical to a product's success
• Lessons learned of how others have balanced these competing restrictions to bring a product to market that has the right features at the right cost

BP2. Speed to Market via Cross Functional Alignment

CO-FACILITATOR:

Stuart Karten, Principal, Karten Design

Raymond Cohen, Former Chief Executive Officer, Vessix Vascular

When you have a proprietary technology or product improvement in a fast-developing field, speed to market is critical for establishing market presence and creating stakeholder value. Companies can improve their product’s speed to market by creating efficient cross-functional teams to simultaneously execute on a shared vision.This interactive session will feature a case history from Raymond W. Cohen, serial entrepreneur and former CEO of Vessix Vascular, which he sold to Boston Scientific in November 2012 (in a structured transaction valued at $425 million) within 18 months of kicking off product development.

Key Take-Aways:

• Insights on creating and communicating a compelling vision that rallies your cross-functional team around critical product development objectives
• Best practices for assembling and empowering a team trusted of leaders including pitfalls of creating and managing cross-functional teams
• Tools and strategies for successfully aligning your R&D, engineering, regulatory, clinical, marketing, and product design team members

BP3. Inside Hospital Technology Assessment & Evidence-Based Decision Making

CO-FACILITATORS:

Thomas Skorup, Vice President, Applied Solutions, ECRI

Kent Soo Hoo, PhD, Director, Healthcare Technology Assessment Program (HTAP), UCSF Medical Center
 
Providers have increasingly sought to make their technology decision-making process more evidenced-based, fact driven, and team based.  Excellent goals, no doubt, but what does this all mean for suppliers?  How do suppliers and providers themselves “collaborate” to create an effective healthcare supply chain?  And what evidence are providers really looking for to make their decisions?

Key Take-Aways:

• Gain insight into current trends and priorities for technology decision-making at healthcare providers
• Examples of facts and evidence that truly “make a difference” in decisions made today
• Learn to speak to and collaborate with the multiple provider stakeholders involved in making technology decisions in today’s climate of health reform 

Networking, Refreshment, and Exhibition Break

ASK THE EXPERTS! PANEL DISCUSSION

Savvy Partnering for Innovation

MODERATOR:

Mark Kemp, President of Medical, Flextronics

PANELISTS INCLUDE:

Erik Barnes, Director, R&D - Pyxis, CareFusion

Curtis Bloch, Vice President, Sales & Marketing, Tangent Medical Technologies

Joseph Condurso, Chief Executive Officer, President & Director, PatientSafe Solutions

Parimal Shah, Director, Program Management Office, Covidien

Richard King, President & Chief Executive Officer, AcelRx Pharmaceuticals

Effective collaboration is a becoming paramount to the successful implementation of innovative opportunities, whether looking at technology partnerships, M&A, distribution partnerships, open innovation or other models. This session will focus on the experiences and actions where collaborative innovation led to mutual success.

Key Take-Aways:

• Insight on asking the right questions throughout the collaboration process to establish sustainable, productive relationships
• Principles and extendable best practices for innovation collaboration that can improve the probability of success
• Framework for defining/having the ‘right innovation culture’ between partners and is this something that can be created systematically?

Customers in Flux: Emerging Profiles & Purchasing Behaviors

Wendell Raddatz, Vice President, Strategic Accounts & Contracting, Biomet

As the key provisions from healthcare reform legislation are implemented, there will be an increasing impact on existing customer relationships and the criteria hospitals/purchasing groups request during the technology acquisition process. With these additional pressures, the entire ecosystem of who will purchase and how they'll purchase will continue to shift the medical device landscape.

Key Take-Aways:

• Insight on who the customer really is: the surgeon, the hospital administration or the purchasing manager, and what kind of relationships need to be created with each
• Insights into how the evidence-based and/or patient-centered outcomes models are affecting hospital outlooks and attitudes
• Examples of strategies for meeting the higher bar set by purchasing committees

Sessions Conclude

Can the FDA Spur Innovation?

Megan Moynahan, Assistant Director for Technology and Innovation, FDA Center for Devices and Radiological Health

It’s an open question whether a regulatory agency can spur innovation in the industry it regulates. To handle truly innovative products against the vast tide of typical products it regulates, the FDA needs to cultivate both an “innovation mindset” and a “production mindset” – two opposing internal cultures that give rise to different processes and practices.

Key Take-Aways:

• Spurring innovation requires recognizing what is innovative, disruptive or game-changing
• The opposing cultures of “production” and “innovation” can co-exist in an organization, but only a thriving culture of innovation at the FDA will bring about the kind of transformative change needed to address long-standing trends
• Industry can help FDA grow its emerging culture of innovation

Doing the Right Thing

Joe Kiani, Chairman & Chief Executive Officer, Masimo Corporation

With cost pressures mounting and healthcare inflation rising, there is a recipe for Doing the Right Thing that can protect patients, fuel innovation and reduce costs in our healthcare system.

Key Take-Aways:

• Success factors for changing incentives so that people and organizations can be accountable and take ownership
• Lessons learned that investing in innovation doesn’t drive up costs — with the right breakthroughs, it could be one of our best shots at containing costs
• Outcomes of  how “doing the right thing”  - connecting the dots between patients, providers, technology and regulators, can go a long way in reducing costs

Developing Innovative IP Strategies in a Global Economy

Brian Szymczak, Associate General Counsel, Director of Intellectual Property, ArthroCare Corporation

Our companies are increasingly looking to new and uncharted waters to generate growth.  When contemplating entry into a new and underdeveloped market, what IP protection is available and is it worth the trouble?  When is your IP protection "good enough" to venture out?

Key Take-Aways:

• Guide to setting appropriate expectations about the scope and enforcement of patent protections in emerging economies
• Tools to draw a line in the sand with your brand
• Balancing the risks and opportunities of entering emerging markets
• Insight on reviewing and improving your trade secret protection

Networking, Refreshment, and Exhibition Break

Featuring:
The Power Showcase

A simultaneous demonstration of products, services and solutions. Find the company that most intrigues you, grab a chair and hear their story.

Breakout Sessions: Create, Communicate & Connect

Participant-driven discussions focusing on your key challenges
and concerns.

Choose one of the following:

TT1. Mapping the Innovation Maturity Curve

CO-FACILITATORS:
Sean MacLeod, President, Stratos Product Development

Jennifer Samproni, Senior Manager, R&D, Siemens Healthcare Diagnostics

How many times a day do you hear the word “innovation?” The medical device space is unique in its ability to harness innovation as a competitive advantage. However, the non-tangible aspects of innovation make it hard to recognize if you’ve truly achieved sustainable success. There are some key elements of innovation maturity that require continual evolution.  Join us for this Think Tank about these key elements and the maturity of your own organization within the innovation continuum.

Key Take-Aways:

• Discover the elements that make-up the innovation curve
• Map your organization on this curve and learn key steps that will enhance your ability to continue to evolve
• Explore a case study on how an organization moved to a future state of innovation success

TT2. Understanding Emerging Market Customers & Cultures

CO-FACILITATORS:
Donna Doty, Vice President, Healthcare, GfK

Chareen Lim, Vice President, Healthcare, GfK

So-called “Emerging” markets have already emerged - bringing new technologies to developing geographies requires savvy product launch planning and go-to-market strategies. This interactive session will guide you through the ways you can bring sharper insight to your launch / planning strategy, using creative techniques and advanced research.

Key Take-Aways:

• Insight on the critical information that needs to be understood at the government, systems, cultural levels
• Roadmap of how to most efficiently execute insight into “navigating” the market – i.e. what can be understood via desk research, primary research, internal knowledge
• Guidelines and creative ways of how to facilitate and leverage internal knowledge

TT3. mHealth: At the Forefront of Future Medicine

FACILITATOR:
Anthony Shimkin, Senior Director, Qualcomm Life

There has been a lot in the news on the promise of mobile health care or mHealth.  But how do we know what's real and when?  Is this just a new connectivity channel or something much bigger?  What should we expect both here in the US and in emerging regions as well?

Key Take-Aways:

• Update on adoption of mHealth solutions
• Key barriers of acceptance for consumers and professionals
• Insights into desired market solutions
• Lessons learned to date

Food For Thought - Networking Luncheon

Thought Leaders host a menu of luncheon discussions on pertinent industry issues. Dine and dish with industry experts. The list of discussion topics will be available onsite.

Session to Session Travel Time

The Who, How and If’s of Reimbursement

Elizabeth Trevino-Miller, Director, Healthcare Economics & Reimbursement, LifeCell Corporation, part of Kinetic Concepts, Inc. (KCI)

How will the changes in healthcare impact device manufactures? Who will pay for medical devices, how will they be reimbursed or is there a chance that they won't be reimbursed?

Key Take-Aways:

• Framework of the historic trends in healthcare and impact on reimbursement
• Insight on the current state of changes
• Success factors and considerations for the future

The Must-Have Elements of Innovation Realization

Abhi Chavan, PhD, Vice President of Research, Product Development and Manufacturing Operations, Corventis

We often hear about the need for innovation as a reaction to current solutions which are sub-optimal or challenging business conditions. However, often there is a lack of clarity on what needs to be achieved and what the follow through actions are. Is this just a wacky impulse or will the innovation result in a material contribution to the top or bottom line? Is there a tangible end goal and what is the minimum framework to ensure success?

Key Take-Aways:

• Guide to conceptualizing that innovation needs a thoughtfully laid out pathway to realization, including financial goals
• In today’s fast changing technology framework, how do you ensure that proposed outcome of the innovation is not blindsided by alternative options, created by tectonic shifts in technology
• Guide to the need for landscape assessments of intellectual property, government policies and regulatory requirements

Breakout Sessions: Create, Communicate & Connect

Participant-driven discussions focusing on your key challenges
and concerns.

Choose one of the following:

PC1. Creating Demand for Medical Devices: Setting Your Products Apart with Interactivity

FACILITATOR:
Gavin Finn, President & Chief Executive Officer, Kaon Interactive

Three of the biggest challenges facing medical device companies today include differentiating your products, demonstrating how the product works in a static environment and communicating your value proposition to multiple audiences. This highly interactive session will delve into interactive technologies that transcend traditional practices to address these issues.

Key Take-Aways:

• Lessons learned in using interactivity to increase product knowledge retention
• Action steps and techniques on how to tell your product story interactively
• Best practices for tailoring your interactive product content to multiple audiences in the buying cycle and to multiple divisions within your organization (marketing, R&D, training, sales, business development)

PC2. Leveraging Partnerships for R&D Efficiency and Effectiveness

CO-FACILITATORS:

Sunil Mittal, Head of Client Services, Medical Devices, InfoSys

Mark Strong, Vice President, CRV R&D, Boston Scientific

Learn how an industry-leading medical device R&D division embarked on a journey to be more innovative, efficient & cost effective, leveraging R&D process transformation and adopting a global development model.

Key Take-Aways:

• Case history of the Boston Scientific journey leveraging external partners for innovation & growth within R&D
• Insight on which development model (agile, waterfall or hybrid) is best suited for medical devices development?
• Framework for creating an extended global team for optimal results

Frost & Sullivan Analyst Insight Panel

MODERATOR:

Greg Caressi, Senior Vice President, Healthcare & Life Sciences, Frost & Sullivan

PANELISTS INCLUDE:

Aarti Shetty, Senior Industry Analyst, Medical Devices, Frost & Sullivan

Roberto Aranibar, Industry Analyst, Medical Imaging, Frost & Sullivan

Charlie Whelan, Director of Consulting, Healthcare & Life Sciences, Frost & Sullivan

Venkat Rajan, Industry Manager, Medical Devices, Frost & Sullivan

 
During this interactive forum, our analyst team will offer their views of key takeaways from the discussions, and invite audience perspectives and questions regarding industry opportunities, challenges and threats. Participants should come prepared with issues to discuss with the Frost & Sullivan analyst team and your executive colleagues.
 

Weighing In on the Golden Nuggets from our 18th Annual Medical Devices Executive MindXchange

SESSION LEADERS INCLUDE:

Al Di Rienzo, President & Chief Executive Officer, Blue Highway

Dan Mooradian, Chief Science Officer, Innova Medical Design, Inc.

Participants at each Executive MindXchange come away with a wealth of learnings and it can be a challenge to take it all in. During this interactive session members of our Advisory Board will highlight the most important themes, key take-aways and lessons learned as a capstone for the event.
 

18th Annual Medical Devices Executive MindXchange Concludes